-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC THERAPEUTICS, INC. : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM VS MARKET PERFORM RATING; TARGET PRICE $98 VS $70

Reuters·09/14/2026 10:04:01

Please log in to view news